Trial Profile
A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Selonsertib (Primary) ; Prednisolone
- Indications Alcoholic hepatitis
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases
- 31 May 2018 Status changed from active, no longer recruiting to completed.
- 08 Jan 2018 Status changed from recruiting to active, no longer recruiting.